Clinical Trial Update: Role of CX3CR1-expressing Cells in Hematologic Malignancy

View source ↗

Summary

A clinical trial update examining the role of CX3CR1-expressing cells in hematologic malignancies, including Diffuse Large B-Cell Lymphoma and Multiple Myeloma,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Multiple Myeloma

Snippet

Sponsor: Saint Vincent's Hospital, Korea | Conditions: CX3CR1 Protein, Diffuse Large B Cell Lymphoma | Status: UNKNOWN